BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17676392)

  • 1. Effect of neurolytic celiac plexus block guided by computerized tomography on pancreatic cancer pain.
    Zhang CL; Zhang TJ; Guo YN; Yang LQ; He MW; Shi JZ; Ni JX
    Dig Dis Sci; 2008 Mar; 53(3):856-60. PubMed ID: 17676392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of consecutive neurolytic celiac plexus block (NCPB) technique outcomes in the management of refractory visceral cancer pain.
    Yang FR; Wu BS; Lai GH; Wang Q; Yang LQ; He MW; Ni JX
    Pain Med; 2012 Apr; 13(4):518-21. PubMed ID: 22360763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial.
    Wong GY; Schroeder DR; Carns PE; Wilson JL; Martin DP; Kinney MO; Mantilla CB; Warner DO
    JAMA; 2004 Mar; 291(9):1092-9. PubMed ID: 14996778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain.
    Süleyman Ozyalçin N; Talu GK; Camlica H; Erdine S
    Eur J Pain; 2004 Dec; 8(6):539-45. PubMed ID: 15531222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy.
    Stefaniak T; Basinski A; Vingerhoets A; Makarewicz W; Connor S; Kaska L; Stanek A; Kwiecinska B; Lachinski AJ; Sledzinski Z
    Eur J Surg Oncol; 2005 Sep; 31(7):768-73. PubMed ID: 15923103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief.
    Rykowski JJ; Hilgier M
    Anesthesiology; 2000 Feb; 92(2):347-54. PubMed ID: 10691219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of analgesic efficacy of neurolytic celiac plexus block in patients with unresectable pancreatic cancer: the importance of timing.
    Yoon DM; Yoon KB; Baek IC; Ko SH; Kim SH
    Support Care Cancer; 2018 Jun; 26(6):2023-2030. PubMed ID: 29344736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined neurolytic block of celiac and superior hypogastric plexuses for incapacitating upper abdominal cancer pain.
    Huang L; Tao F; Wang Z; Wan H; Qu P; Zheng H
    J BUON; 2014; 19(3):826-30. PubMed ID: 25261674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of epidural butamben to celiac plexus neurolytic block for the treatment of the pain of pancreatic cancer.
    Shulman M; Harris JE; Lubenow TR; Nath HA; Ivankovich AD
    Clin J Pain; 2000 Dec; 16(4):304-9. PubMed ID: 11153785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurolytic celiac plexus block: a better alternative to opioid treatment in upper abdominal malignancies: an Indian experience.
    Jain PN; Shrikhande SV; Myatra SN; Sareen R
    J Pain Palliat Care Pharmacother; 2005; 19(3):15-20. PubMed ID: 16219607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer.
    Yan BM; Myers RP
    Am J Gastroenterol; 2007 Feb; 102(2):430-8. PubMed ID: 17100960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT guided neurolytic blockade of the coeliac plexus in patients with advanced and intractably painful pancreatic cancer.
    Rosland JH; Geitung JT
    Scand J Pain; 2018 Apr; 18(2):247-251. PubMed ID: 29794300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic versus open approach to neurolytic celiac plexus block in inoperable pancreatic cancer.
    Tepelenis K; Tsimogiannis KE; Zikos N; Koulas S; Pappas-Gogos G; Benetatos N; Tsimogiannis I; Tsimoyiannis EC
    ANZ J Surg; 2018 Nov; 88(11):E767-E771. PubMed ID: 29763984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiac block for the treatment of pancreatic pain.
    Ischia S; Polati E; Finco G; Gottin L
    Curr Rev Pain; 2000; 4(2):127-33. PubMed ID: 10998724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study between 2 protocols for management of severe pain in patients with unresectable pancreatic cancer: one-year follow-up.
    Amr YM; Makharita MY
    Clin J Pain; 2013 Sep; 29(9):807-13. PubMed ID: 23917696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurolytic celiac plexus block for pancreatic cancer pain.
    Brown DL; Bulley CK; Quiel EL
    Anesth Analg; 1987 Sep; 66(9):869-73. PubMed ID: 3619093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR-guided neurolytic celiac plexus ablation: an evaluation of effect and injection spread pattern in cancer patients with celiac tumor infiltration.
    Akural E; Ojala RO; Järvimäki V; Kariniemi J; Tervonen OA; Blanco Sequeiros R
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):472-8. PubMed ID: 22588275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis.
    Eisenberg E; Carr DB; Chalmers TC
    Anesth Analg; 1995 Feb; 80(2):290-5. PubMed ID: 7818115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain.
    Kawamata M; Ishitani K; Ishikawa K; Sasaki H; Ota K; Omote K; Namiki A
    Pain; 1996 Mar; 64(3):597-602. PubMed ID: 8783327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life.
    Mercadante S; Catala E; Arcuri E; Casuccio A
    J Pain Symptom Manage; 2003 Dec; 26(6):1140-7. PubMed ID: 14654266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.